|
⚲
|
| Keyboard |
| Commodore Capital LP | |
|---|---|
| Firm | |
| Address | 444 Madison Avenue, 35th Floor New York, NY 10022 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Commodore Capital Offshore Ltd | 021-390658 | Executive Officer | 637.3 M | ||
| Commodore Capital LP | |||||
| Commodore Capital Master LP | 021-390655 | Executive Officer | 891.5 M | 2,369.3 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2024-01-10 | Sell | 1,050,000 | $18.00 | 18,900,000 |
|
Vistagen Therapeutics Inc VTGN
Pre-Funded Warrants (Right to Buy) · derivative
|
2023-10-04 | Grant | 2,788,620 | ||
|
Vistagen Therapeutics Inc VTGN
Tranche 1 Warrants (Right to Buy) · derivative
|
2023-10-04 | Grant | 1,394,310 | ||
|
Vistagen Therapeutics Inc VTGN
Tranche 2 Warrants (Right to Buy) · derivative
|
2023-10-04 | Grant | 1,690,014 | ||
|
Vistagen Therapeutics Inc VTGN
Common Stock
|
2023-08-07 | Buy | 775,756 | $23.15 | 17,958,751 |
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2023-06-20 | Buy | 448,217 | $15.17 | 6,799,452 |
|
Enliven Therapeutics Inc ELVN
Common stock, par value $0.001 per share
|
2023-02-23 | Other | 729,891 | ||
|
Enliven Therapeutics Inc ELVN
Common stock, par value $0.001 per share
|
2023-02-23 | Buy | 621.75 | $22.07 | 13,722 |
|
Enliven Therapeutics Inc IMRA
Common stock, par value $0.001 per share
|
2023-02-22 | Buy | 23,565 | $5.11 | 120,417 |
|
Enliven Therapeutics Inc IMRA
Common stock, par value $0.001 per share
|
2023-02-21 | Buy | 8,194 | $5.25 | 43,018 |
|
Satsuma Pharmaceuticals Inc STSA
Common Stock, par value $0.0001 per share
|
2022-11-14 | Sell | 3,250,000 | $0.71 | 2,307,500 |
|
Satsuma Pharmaceuticals Inc STSA
Common Stock, par value $0.0001 per share
|
2021-11-24 | Buy | 2,922 | $5.42 | 15,837 |
|
Satsuma Pharmaceuticals Inc STSA
Common Stock, par value $0.0001 per share
|
2021-11-22 | Buy | 9,979 | $5.49 | 54,785 |
|
Satsuma Pharmaceuticals Inc STSA
Common Stock, par value $0.0001 per share
|
2021-11-19 | Buy | 3,225 | $5.44 | 17,544 |
|
Satsuma Pharmaceuticals Inc STSA
Common Stock, par value $0.0001 per share
|
2021-11-11 | Buy | 7,941 | $6.05 | 48,043 |
|
Satsuma Pharmaceuticals Inc STSA
Common Stock, par value $0.0001 per share
|
2021-11-10 | Buy | 9,622 | $5.85 | 56,289 |
|
Satsuma Pharmaceuticals Inc STSA
Common Stock, par value $0.0001 per share
|
2021-11-08 | Buy | 560 | $5.99 | 3,354 |
|
Satsuma Pharmaceuticals Inc STSA
Common Stock, par value $0.0001 per share
|
2021-11-05 | Buy | 7,800 | $5.95 | 46,410 |
|
Satsuma Pharmaceuticals Inc STSA
Common Stock, par value $0.0001 per share
|
2021-11-04 | Buy | 1,400 | $5.88 | 8,232 |
|
Satsuma Pharmaceuticals Inc STSA
Common Stock, par value $0.0001 per share
|
2021-11-02 | Buy | 8,880 | $5.64 | 50,083 |
| showing 20 of 29 most recent transactions | |||||